At Adaptis, we provide comprehensive solutions that empower healthcare
companies,
ensuring success across global markets with expert consulting in
pharmacovigilance and regulatory affairs.
Pharmacovigilance is monitoring and ensuring the safety of pharmaceutical products through vigilant adverse event reporting, risk management, and safety surveillance.
Regulatory affairs ensures that the pharmaceutical products comply with all regulations and laws governing their development, manufacturing, marketing, and distribution across the globe.
As the pharmaceutical manufacturers are facing an increasingly competitive environment and they are seeking out opportunities to reduce production costs.
A dedicated team of pharmacovigilance (PV) and regulatory affairs (RA) experts, offering integrated approach from initial submissions to post-approval processes, ensuring synergies at every stage.
Backed by extensive experience, including hands-on expertise in facing and clearing health authority inspections including pharmacovigilance and regulatory compliance audits.
With strong operational frameworks and efficient delivery systems, we ensure the highest quality of service, meeting stringent timelines without compromising on standards.
Adaptis consistently demonstrates excellence and reliability in the global healthcare landscape by handling end-to end pharmacovigilance and regulatory operations for multiple clients.
Voices of Trust, Stories of Success.
Partnering with Adaptis has significantly enhanced our regulatory and pharmacovigilance
functions. Their expertise in end-to-end regulatory operations—from document compilation
and dossier review to seamless ANDA submissions and query resolutions—has been
invaluable.
Adaptis’s exceptional management of our pharmacovigilance functions ensures compliance
and precise safety monitoring. Their professionalism, meticulous attention to detail, and
proactive approach make them a trusted partner for all our regulatory and
pharmacovigilance needs.
The team at Adaptis made what seemed like a daunting regulatory process feel effortless.
Their dedication and personalized solutions have greatly benefited our operations. Highly
recommended!
Adaptis consulting services are top-notch. Their insights and strategies have not only
supported us in USFDA safety audit observation clearance but also upgraded our
pharmacovigilance systems for future compliance.
Adaptis went above and beyond to address our unique challenges. Their team’s dedication
and expertise in pharmacovigilance have contributed in our product’s post approval
surveillance. Outstanding service!
Stay Informed, Stay Ahead with Adaptis
In today’s ever-evolving and highly regulated pharmaceutical landscape, managing regulatory affairs (RA) and pharmacovigilance (PV) has become a critical and resource-intensive responsibility.
Patient safety is a crucial part of healthcare that seeks to protect patients from harm during their treatment and care.
21 CFR 314.80 is a regulation established by the U.S. Food and Drug Administration (FDA) to govern the post marketing reporting of adverse drug experiences.
Adaptis is delighted to announce the signing of a Memorandum of Understanding (MoU) with Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Pune. This partnership aims to bridge the gap between academia and industry, fostering collaboration and expertise in the pharmaceutical sector.
With immense gratitude and joy, we celebrated the inauguration of our new office—a milestone made possible by unwavering support and blessings. The pooja and lamp-lighting ceremony symbolized the start of a journey filled with hope, unity, and ambition.